GlassScriptPhysician profile
Chad Alan Miller
NPI 1235113895
$2,373.28
in general payments reported to CMS, 2019-2025
27 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $226 · 2021: $233 · 2022: $207 · 2023: $183 · 2024: $929 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $675 · Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $675.38 |
| Food and Beverage | $577.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $675.38 | 2024 | |
| Smith+Nephew, INC. | $316.01 | 2019-2023 | Grafix Pl |
| Stryker Corporation | $230.64 | 2019-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse |
| Paratek Pharmaceuticals, INC. | $182.70 | 2019-2025 | Nuzyra |
| Horizon Therapeutics Plc | $162.80 | 2019-2021 | |
| Legacy Ortho LLC | $139.71 | 2024 | |
| Convatec INC. | $102.95 | 2023-2024 | |
| Organogenesis INC. | $90.38 | 2020-2021 | |
| Depuy Synthes Sales INC. | $67.21 | 2020-2025 | Dynacord, Dynatape, Healix Knotless Peek |
| Nevro Corp. | $58.05 | 2022-2023 | Senza |
| Mimedx Group, INC. | $36.54 | 2024 | |
| Next Science LLC | $32.75 | 2024 | Surgx, Blastx, Xperience |
| Treace Medical Concepts, INC. | $31.56 | 2023 | |
| Nabriva Therapeutics, Plc | $29.93 | 2021 | |
| Polarityte, INC. | $29.44 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.29 | 2021-2023 | Activ.A.C. |
| Paragon 28, INC. | $18.72 | 2019-2020 | |
| Medtronic, INC. | $18.37 | 2021 | |
| Osiris Therapeutics INC. | $18.25 | 2019 | |
| Tenex Health INC. | $18.05 | 2021 | |
| Hikma Pharmaceuticals USA | $16.47 | 2019 | |
| Boston Scientific Corporation | $16.35 | 2019 | |
| Acera Surgical, INC. | $16.00 | 2025 | Restrata Wound Matrix |
| Orthofix Medical, INC. | $14.11 | 2022 | |
| Alfasigma USA, INC. | $12.48 | 2021 | |
| Zyla Life Sciences, INC. | $12.14 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.